Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 557,540 | 609,759 | 545,557 | 559,355 | 497,633 |
| Cost of Goods | 379,354 | 394,371 | 351,327 | 358,836 | 323,062 |
| Gross Profit | 178,186 | 215,388 | 194,230 | 200,519 | 174,571 |
| Operating Expenses | 144,091 | 179,727 | 150,204 | 399,973 | 151,328 |
| Operating Income | 34,449 | 36,032 | 44,353 | -198,618 | 23,305 |
| Interest Expense | 49,315 | 47,028 | 42,391 | 35,623 | 33,335 |
| Other Income | 5,440 | 3,341 | 218 | 1,510 | 109 |
| Pre-tax Income | -9,426 | -7,655 | 2,180 | -232,731 | -9,921 |
| Income Tax | 668 | -1,797 | 4,570 | 7,350 | -3,461 |
| Net Income Continuous | -10,094 | -5,858 | -2,390 | -240,081 | -6,460 |
| Minority Interests | -3,151 | -1,525 | 299 | -119,273 | -4,304 |
| Net Income | $-6,943 | $-4,333 | $-2,689 | $-120,808 | $-2,156 |
| EPS Basic Total Ops | -0.05 | -0.03 | -0.02 | -0.80 | -0.01 |
| EPS Basic Continuous Ops | -0.07 | -0.04 | -0.02 | -1.59 | -0.04 |
| EPS Diluted Total Ops | -0.05 | -0.03 | -0.02 | -0.80 | -0.01 |
| EPS Diluted Continuous Ops | -0.07 | -0.04 | -0.02 | -1.59 | -0.04 |
| EPS Diluted Before Non-Recurring Items | 0.10 | 0.21 | 0.12 | N/A | N/A |
| EBITDA(a) | $94,657 | $99,194 | $108,062 | $-136,729 | $83,315 |